ProfJarushka Naidoo

Prof. Naidoo is a consultant medical oncologist at Beaumont Hospital Dublin and a Professor in RCSI. Prior to joining RCSI in late 2020, Prof Naidoo was an Assistant Professor of Medical Oncology and Lung Cancer Specialist in Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, and is now an Adjunct Assistant Professor of Oncology at Johns Hopkins University She currently serves as national lung cancer lead for Cancer Trials Ireland.
Prof. Naidoo is an internationally-recognized leader in the fields of immunotherapy for lung cancer, melanoma, and immune-related toxicity. She serves on several international guideline panels including ASCO (Americal Society of Cliical Oncology) and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed and completed several investigator-initiated, industry-funded and cooperative group clinical trials. She has received a number of grants including a young investigator award from the the International Association for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career development award from the National Institutes of Health (NIH) KL2-program. She has a strong commitment to education and training in Oncology, and has mentored several early career physicians, fellows and medical students, resulting in high-level publications and young investigator award winners.

Dr. Naidoo obtained her medical degree from Trinity College Dublin, completed her internal medicine and medical oncology training in Ireland, followed by an advanced medical oncology Fellowship at Memorial Sloan Kettering Cancer Center, New York, before joining the faculty at Johns Hopkins, and then returning to Ireland